Guillem Singla Buxarrais

Neurofenix

Guillem Singla Buxarrais is co-founder and CEO of Neurofenix, the company building revolutionary devices to improve rehabilitation. Guillem has worked on cutting-edge research at the Brain and Behaviour Lab at the UK's leading Department of Bioengineering, Imperial College.

He built the NeuroBall working alongside physiotherapists from Brunel University London. He used his extensive experience and hundreds of hours volunteering with stroke survivors to create the NeuroBall. The NeuroBall is a revolutionary games controller that makes upper limb rehabilitation more engaging and accessible.

Guillem is an innovative Biomedical Engineer who has received recognition from the Institute of Engineering and Technology and The Royal Academy of Engineering. He was also awarded the prestigious Inventor Prize by Nesta and the Department for Business, Energy and Industrial Strategy (BEIS). The award recognised the profound impact the Neuroball will have on the lives of millions of stroke survivors worldwide.

dont miss

How to utilise the Neuroscience of habits for rehabilitation

When you got ready this morning, did you put on your left or right shoe first? Don’t know the answer? You are not alone. Habits shape our everyday lives. In this seminar, you’ll learn about the neuroscience behind habit formation. We explore how we can utilise this to build habits for success in rehabilitation… and everything else.

EVEN MORE SEMINARS

  • Dr. Susan Mollan: Speaking at the European Neurological Convention

    Dr. Susan Mollan
    University Hospitals Birmingham NHS Foundation Trust

    What every neurologist needs to know about optical coherence tomography

  • Dr Terry Gorst: Speaking at the European Neurological Convention

    Dr Terry Gorst
    University of Plymouth

    ‘To sense is to move’: the sensory aspects of movement in Parkinson’s disease and stroke

  • Philippe AUVRAY: Speaking at the European Neurological Convention

    Philippe AUVRAY
    NEURALLYS

    Ambulatory Intracranial pressure monitoring: a revolution for shunted patients and neurosurgeons

  • Maroun Farah: Speaking at the European Neurological Convention

    Maroun Farah
    Senso Medical Labs

    BioPot platform: development of EEG, EMG and Bioimpedance patch and tattoo wearables

  • Prof Jon Marsden: Speaking at the European Neurological Convention

    Prof Jon Marsden
    University of Plymouth

    Vestibular dysfunction in Multiple Sclerosis